Cargando…

Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys

We evaluate the utility of the National Surveys of Attitudes and Sexual Lifestyles (Natsal) undertaken in 2000 and 2010, before and after the introduction of the National Chlamydia Screening Programme, as an evidence source for estimating the change in prevalence of Chlamydia trachomatis (CT) in Eng...

Descripción completa

Detalles Bibliográficos
Autores principales: Kounali, D. Z., Welton, N. J, Soldan, K., Woodhall, S. C., Dunbar, J. Kevin, Migchelsen, S. J., Mercer, C. H., Horner, P., Ades, A. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518515/
https://www.ncbi.nlm.nih.gov/pubmed/30869031
http://dx.doi.org/10.1017/S0950268819000347
_version_ 1783418466204647424
author Kounali, D. Z.
Welton, N. J
Soldan, K.
Woodhall, S. C.
Dunbar, J. Kevin
Migchelsen, S. J.
Mercer, C. H.
Horner, P.
Ades, A. E.
author_facet Kounali, D. Z.
Welton, N. J
Soldan, K.
Woodhall, S. C.
Dunbar, J. Kevin
Migchelsen, S. J.
Mercer, C. H.
Horner, P.
Ades, A. E.
author_sort Kounali, D. Z.
collection PubMed
description We evaluate the utility of the National Surveys of Attitudes and Sexual Lifestyles (Natsal) undertaken in 2000 and 2010, before and after the introduction of the National Chlamydia Screening Programme, as an evidence source for estimating the change in prevalence of Chlamydia trachomatis (CT) in England, Scotland and Wales. Both the 2000 and 2010 surveys tested urine samples for CT by Nucleic Acid Amplification Tests (NAATs). We examined the sources of uncertainty in estimates of CT prevalence change, including sample size and adjustments for test sensitivity and specificity, survey non-response and informative non-response. In 2000, the unadjusted CT prevalence was 4.22% in women aged 18–24 years; in 2010, CT prevalence was 3.92%, a non-significant absolute difference of 0.30 percentage points (95% credible interval −2.8 to 2.0). In addition to uncertainty due to small sample size, estimates were sensitive to specificity, survey non-response or informative non-response, such that plausible changes in any one of these would be enough to either reverse or double any likely change in prevalence. Alternative ways of monitoring changes in CT incidence and prevalence over time are discussed.
format Online
Article
Text
id pubmed-6518515
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-65185152019-06-04 Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys Kounali, D. Z. Welton, N. J Soldan, K. Woodhall, S. C. Dunbar, J. Kevin Migchelsen, S. J. Mercer, C. H. Horner, P. Ades, A. E. Epidemiol Infect Original Paper We evaluate the utility of the National Surveys of Attitudes and Sexual Lifestyles (Natsal) undertaken in 2000 and 2010, before and after the introduction of the National Chlamydia Screening Programme, as an evidence source for estimating the change in prevalence of Chlamydia trachomatis (CT) in England, Scotland and Wales. Both the 2000 and 2010 surveys tested urine samples for CT by Nucleic Acid Amplification Tests (NAATs). We examined the sources of uncertainty in estimates of CT prevalence change, including sample size and adjustments for test sensitivity and specificity, survey non-response and informative non-response. In 2000, the unadjusted CT prevalence was 4.22% in women aged 18–24 years; in 2010, CT prevalence was 3.92%, a non-significant absolute difference of 0.30 percentage points (95% credible interval −2.8 to 2.0). In addition to uncertainty due to small sample size, estimates were sensitive to specificity, survey non-response or informative non-response, such that plausible changes in any one of these would be enough to either reverse or double any likely change in prevalence. Alternative ways of monitoring changes in CT incidence and prevalence over time are discussed. Cambridge University Press 2019-03-04 /pmc/articles/PMC6518515/ /pubmed/30869031 http://dx.doi.org/10.1017/S0950268819000347 Text en © NIHR Health Protection Research Unit in Evaluation of Interventions 2019 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Kounali, D. Z.
Welton, N. J
Soldan, K.
Woodhall, S. C.
Dunbar, J. Kevin
Migchelsen, S. J.
Mercer, C. H.
Horner, P.
Ades, A. E.
Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys
title Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys
title_full Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys
title_fullStr Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys
title_full_unstemmed Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys
title_short Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys
title_sort has chlamydia trachomatis prevalence in young women in england, scotland and wales changed? evidence from national probability surveys
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518515/
https://www.ncbi.nlm.nih.gov/pubmed/30869031
http://dx.doi.org/10.1017/S0950268819000347
work_keys_str_mv AT kounalidz haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT weltonnj haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT soldank haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT woodhallsc haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT dunbarjkevin haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT migchelsensj haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT mercerch haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT hornerp haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys
AT adesae haschlamydiatrachomatisprevalenceinyoungwomeninenglandscotlandandwaleschangedevidencefromnationalprobabilitysurveys